Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABT Abbott Laboratories	$132.10 +0.3%	$130.74	$99.71 ▼ $141.23	$229.10B	0.7	5.87 million shs	4.23 million shs
CAH Cardinal Health	$138.82 +1.2%	$128.78	$93.17 ▼ $139.18	$33.53B	0.66	2.11 million shs	1.40 million shs
CI The Cigna Group	$332.09 +0.3%	$306.43	$262.03 ▼ $370.83	$90.89B	0.5	1.65 million shs	1.11 million shs
CVS CVS Health	$68.14 +0.2%	$62.72	$43.56 ▼ $75.27	$85.91B	0.54	11.57 million shs	6.40 million shs
FMS Fresenius Medical Care	$24.73 0.0%	$24.09	$17.93 ▼ $25.25	$14.51B	0.93	312,773 shs	204,255 shs
HCA HCA Healthcare	$347.48 +0.5%	$325.79	$289.98 ▼ $417.14	$85.55B	1.68	1.35 million shs	1.25 million shs
MCK McKesson	$694.12 +3.0%	$626.97	$464.42 ▼ $698.76	$86.99B	0.52	839,698 shs	1.20 million shs
MDT Medtronic	$88.97 +0.5%	$91.02	$75.96 ▼ $96.25	$114.11B	0.8	6.57 million shs	5.55 million shs
SYK Stryker	$377.82 +1.2%	$383.41	$314.93 ▼ $406.19	$144.21B	0.95	1.30 million shs	1.80 million shs
UNH UnitedHealth Group	$523.61 +0.1%	$509.06	$436.38 ▼ $630.73	$478.95B	0.62	4.27 million shs	2.37 million shs

The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABT Abbott Laboratories	-0.79%	+4.98%	-4.55%	+16.44%	+17.50%
CAH Cardinal Health	-0.45%	+3.27%	+5.78%	+16.01%	+22.44%
CI The Cigna Group	+0.50%	+4.52%	+7.23%	+19.85%	-9.09%
CVS CVS Health	+0.14%	+2.02%	+3.08%	+51.22%	-14.68%
FMS Fresenius Medical Care	-0.80%	+1.21%	+2.23%	+9.30%	+29.69%
HCA HCA Healthcare	-0.06%	+2.90%	+13.11%	+15.23%	+4.77%
MCK McKesson	+0.13%	+1.75%	+5.22%	+18.32%	+25.74%
MDT Medtronic	-1.60%	-0.02%	-3.82%	+10.77%	+1.68%
SYK Stryker	+0.13%	+0.05%	-3.45%	+3.65%	+5.22%
UNH UnitedHealth Group	-0.29%	+1.83%	+10.11%	+3.38%	+6.86%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABT Abbott Laboratories	4.9014 of 5 stars	2.4	4.0	4.2	4.5	3.5	2.5	2.5
CAH Cardinal Health	4.5139 of 5 stars	2.4	3.0	4.2	3.6	4.0	1.7	1.3
CI The Cigna Group	4.9326 of 5 stars	3.5	4.0	2.5	4.2	4.1	2.5	1.9
CVS CVS Health	4.9085 of 5 stars	2.5	4.0	3.3	3.9	2.9	3.3	3.1
FMS Fresenius Medical Care	3.2458 of 5 stars	1.2	3.0	2.5	0.0	2.3	0.0	5.0
HCA HCA Healthcare	4.9652 of 5 stars	3.4	5.0	1.7	4.5	3.9	2.5	2.5
MCK McKesson	4.4381 of 5 stars	2.5	3.0	3.3	3.0	3.6	2.5	1.3
MDT Medtronic	4.3566 of 5 stars	2.2	4.0	3.3	4.0	2.9	2.5	0.6
SYK Stryker	4.7744 of 5 stars	3.4	3.0	3.3	4.2	3.0	2.5	1.3
UNH UnitedHealth Group	4.9134 of 5 stars	3.5	3.0	4.2	4.0	3.5	3.3	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABT Abbott Laboratories	2.84	Moderate Buy	$137.94	4.42% Upside
CAH Cardinal Health	2.71	Moderate Buy	$140.14	0.95% Upside
CI The Cigna Group	3.00	Buy	$373.25	12.39% Upside
CVS CVS Health	2.90	Moderate Buy	$70.41	3.33% Upside
FMS Fresenius Medical Care	2.33	Hold	$25.30	2.30% Upside
HCA HCA Healthcare	2.83	Moderate Buy	$385.67	10.99% Upside
MCK McKesson	2.93	Moderate Buy	$656.71	-5.39% Downside
MDT Medtronic	2.44	Hold	$96.07	7.98% Upside
SYK Stryker	2.80	Moderate Buy	$421.90	11.67% Upside
UNH UnitedHealth Group	3.10	Buy	$629.32	20.19% Upside

Current Analyst Ratings Breakdown

Latest UNH, MDT, ABT, MCK, CVS, CI, SYK, CAH, HCA, and FMS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/2/2025	MCK McKesson	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$642.00 ➝ $745.00
3/31/2025	CAH Cardinal Health	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$142.00 ➝ $150.00
3/21/2025	CVS CVS Health	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$72.00 ➝ $74.00
3/21/2025	SYK Stryker	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$442.00 ➝ $442.00
3/20/2025	CI The Cigna Group	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$350.00 ➝ $365.00
3/14/2025	MCK McKesson	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$641.00 ➝ $691.00
3/10/2025	ABT Abbott Laboratories	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$133.00 ➝ $150.00
3/4/2025	SYK Stryker	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$422.00
3/4/2025	ABT Abbott Laboratories	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$135.00 ➝ $160.00
3/4/2025	ABT Abbott Laboratories	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$138.00 ➝ $154.00
3/4/2025	MDT Medtronic	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$92.00 ➝ $107.00

(Data available from 4/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABT Abbott Laboratories	$41.95B	5.46	$5.69 per share	23.22	$22.36 per share	5.91
CAH Cardinal Health	$222.28B	0.15	$11.48 per share	12.09	($12.09) per share	-11.48
CI The Cigna Group	$244.38B	0.37	$41.88 per share	7.93	$148.27 per share	2.24
CVS CVS Health	$372.81B	0.23	$9.52 per share	7.16	$60.06 per share	1.13
FMS Fresenius Medical Care	$19.34B	0.75	$4.99 per share	4.96	$27.34 per share	0.90
HCA HCA Healthcare	$70.60B	1.21	$38.82 per share	8.95	$2.23 per share	155.82
MCK McKesson	$344.58B	0.25	$37.76 per share	18.38	($21.58) per share	-32.16
MDT Medtronic	$33.20B	3.44	$7.29 per share	12.21	$38.69 per share	2.30
SYK Stryker	$22.60B	6.38	$14.75 per share	25.62	$54.08 per share	6.99
UNH UnitedHealth Group	$400.28B	1.20	$33.74 per share	15.52	$106.78 per share	4.90

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABT Abbott Laboratories	$13.40B	$7.65	17.27	23.05	2.52	31.95%	20.74%	11.19%	4/16/2025 (Estimated)
CAH Cardinal Health	$852M	$5.36	25.90	15.51	1.49	0.59%	-59.57%	4.17%	5/1/2025 (Estimated)
CI The Cigna Group	$3.43B	$12.24	27.13	10.05	0.98	1.39%	18.61%	4.98%	5/2/2025 (Estimated)
CVS CVS Health	$4.61B	$3.66	18.62	10.06	0.98	1.24%	9.11%	2.71%	4/29/2025 (Estimated)
FMS Fresenius Medical Care	$540.07M	$0.99	20.44	12.88	0.76	3.43%	6.04%	2.69%	5/6/2025 (Estimated)
HCA HCA Healthcare	$5.76B	$21.97	15.82	12.40	1.10	8.16%	586.47%	9.93%	4/25/2025 (Estimated)
MCK McKesson	$3.00B	$21.84	31.78	18.94	1.29	0.82%	-181.26%	5.34%	5/6/2025 (Estimated)
MDT Medtronic	$3.68B	$3.29	27.04	15.26	2.22	12.83%	14.07%	7.70%	5/21/2025 (Estimated)
SYK Stryker	$2.99B	$7.76	48.69	25.48	2.93	13.25%	23.58%	11.37%	4/29/2025 (Estimated)
UNH UnitedHealth Group	$14.41B	$15.50	33.78	15.76	1.37	3.60%	26.69%	8.80%	4/17/2025 (Estimated)

Latest UNH, MDT, ABT, MCK, CVS, CI, SYK, CAH, HCA, and FMS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/29/2025	N/A	SYK Stryker	$2.76	N/A	N/A	N/A	$5.68 billion	N/A
4/25/2025	N/A	HCA HCA Healthcare	$5.77	N/A	N/A	N/A	$18.26 billion	N/A
4/17/2025	N/A	UNH UnitedHealth Group	$7.24	N/A	N/A	N/A	$111.56 billion	N/A
4/16/2025	N/A	ABT Abbott Laboratories	$1.07	N/A	N/A	N/A	$10.38 billion	N/A
2/18/2025	Q3 2025	MDT Medtronic	$1.36	$1.39	+$0.03	$1.01	$8.33 billion	$8.29 billion
2/12/2025	Q4 2024	CVS CVS Health	$0.89	$1.19	+$0.30	$1.30	$96.90 billion	N/A
2/5/2025	Q3 2025	MCK McKesson	$8.60	$8.03	-$0.57	$6.95	$95.86 billion	N/A
1/30/2025	Q2 2025	CAH Cardinal Health	$1.74	$1.93	+$0.19	$1.65	$53.90 billion	N/A
1/30/2025	Q4 24	CI The Cigna Group	$7.84	$6.64	-$1.20	$5.13	$63.18 billion	N/A
1/28/2025	Q4 2024	SYK Stryker	$3.87	$4.01	+$0.14	$1.41	$6.36 billion	N/A
1/24/2025	Q4 24	HCA HCA Healthcare	$6.03	$6.22	+$0.19	$5.63	$18.23 billion	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABT Abbott Laboratories	$2.36	1.79%	+7.17%	30.85%	54 Years
CAH Cardinal Health	$2.02	1.46%	+1.00%	37.69%	28 Years
CI The Cigna Group	$6.04	1.82%	+11.87%	49.35%	N/A
CVS CVS Health	$2.66	3.90%	+9.97%	72.68%	N/A
FMS Fresenius Medical Care	$0.44	1.78%	-8.18%	44.44%	N/A
HCA HCA Healthcare	$2.88	0.83%	+11.20%	13.11%	N/A
MCK McKesson	$2.84	0.41%	+14.33%	13.00%	17 Years
MDT Medtronic	$2.80	3.15%	+4.14%	85.11%	48 Years
SYK Stryker	$3.36	0.89%	+7.82%	43.30%	32 Years
UNH UnitedHealth Group	$8.40	1.60%	+13.46%	54.19%	15 Years

Latest UNH, MDT, ABT, MCK, CVS, CI, SYK, CAH, HCA, and FMS Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/21/2025	ABT Abbott Laboratories	quarterly	$0.59	1.75%	4/15/2025	4/15/2025	5/15/2025
3/20/2025	CVS CVS Health	quarterly	$0.6650	3.89%	4/22/2025	4/22/2025	5/1/2025
2/5/2025	SYK Stryker	quarterly	$0.84	0.86%	3/31/2025	3/31/2025	4/30/2025
2/3/2025	CAH Cardinal Health	quarterly	$0.5056	1.61%	4/1/2025	4/1/2025	4/15/2025
3/6/2025	MDT Medtronic	quarterly	$0.70	3%	3/28/2025	3/28/2025	4/11/2025
1/30/2025	MCK McKesson	quarterly	$0.71	0.47%	3/3/2025	3/3/2025	4/1/2025
1/24/2025	HCA HCA Healthcare	quarterly	$0.72	0.9%	3/17/2025	3/17/2025	3/31/2025
1/30/2025	CI The Cigna Group	quarterly	$1.51	2.1%	3/5/2025	3/5/2025	3/20/2025
2/24/2025	UNH UnitedHealth Group	quarterly	$2.10	1.8%	3/10/2025	3/10/2025	3/18/2025
1/3/2025	CVS CVS Health	quarterly	$0.6650	6.02%	1/23/2025	1/23/2025	2/3/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABT Abbott Laboratories	0.32	1.60	1.14
CAH Cardinal Health	N/A	1.02	0.54
CI The Cigna Group	0.70	0.66	0.72
CVS CVS Health	0.80	0.81	0.60
FMS Fresenius Medical Care	0.42	1.37	1.02
HCA HCA Healthcare	69.07	1.08	0.97
MCK McKesson	N/A	0.88	0.48
MDT Medtronic	0.48	1.90	1.39
SYK Stryker	0.59	1.95	1.32
UNH UnitedHealth Group	0.74	0.83	0.91

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABT Abbott Laboratories	75.18%
CAH Cardinal Health	87.17%
CI The Cigna Group	86.99%
CVS CVS Health	80.66%
FMS Fresenius Medical Care	8.37%
HCA HCA Healthcare	62.73%
MCK McKesson	85.07%
MDT Medtronic	82.06%
SYK Stryker	77.09%
UNH UnitedHealth Group	87.86%

Insider Ownership

Company	Insider Ownership
ABT Abbott Laboratories	0.46%
CAH Cardinal Health	0.09%
CI The Cigna Group	0.70%
CVS CVS Health	0.24%
FMS Fresenius Medical Care	N/A
HCA HCA Healthcare	1.30%
MCK McKesson	0.11%
MDT Medtronic	0.20%
SYK Stryker	5.50%
UNH UnitedHealth Group	0.33%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABT Abbott Laboratories	115,000	1.73 billion	1.73 billion	Optionable
CAH Cardinal Health	46,500	241.57 million	241.35 million	Optionable
CI The Cigna Group	71,300	273.68 million	276.48 million	Optionable
CVS CVS Health	300,000	1.26 billion	1.26 billion	Optionable
FMS Fresenius Medical Care	123,200	586.83 million	N/A	Optionable
HCA HCA Healthcare	294,000	246.20 million	244.37 million	Optionable
MCK McKesson	75,000	125.33 million	125.19 million	Optionable
MDT Medtronic	95,000	1.28 billion	1.28 billion	Optionable
SYK Stryker	51,000	381.69 million	359.07 million	Optionable
UNH UnitedHealth Group	400,000	914.71 million	917.25 million	Optionable

UNH, MDT, ABT, MCK, CVS, CI, SYK, CAH, HCA, and FMS Headlines

Recent News About These Companies

UnitedHealth Group (NYSE:UNH) Shares Down 0.3% - Should You Sell?

April 2 at 1:40 PM | marketbeat.com

SevenBridge Financial Group LLC Has $4.39 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

April 2 at 7:29 AM | marketbeat.com

OneAscent Financial Services LLC Grows Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

April 2 at 7:28 AM | marketbeat.com

Huntington National Bank Trims Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

April 2 at 6:51 AM | marketbeat.com

Te Ahumairangi Investment Management Ltd Trims Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

April 2 at 6:41 AM | marketbeat.com

Meeder Advisory Services Inc. Raises Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

April 2 at 6:25 AM | marketbeat.com

Meeder Asset Management Inc. Decreases Position in UnitedHealth Group Incorporated (NYSE:UNH)

April 2 at 5:05 AM | marketbeat.com

Final Trades: Kinsale Capital, PG&E Corp and UnitedHealth

April 1 at 5:06 PM | youtube.com

UnitedHealth Group (UNH): Among the Best Healthcare Stocks to Buy According to Billionaires

April 1 at 11:29 AM | msn.com

UnitedHealth Group Incorporated (NYSE:UNH) Stake Cut by Scholtz & Company LLC

April 1 at 7:08 AM | marketbeat.com

Groupama Asset Managment Trims Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

April 1 at 7:06 AM | marketbeat.com

May Hill Capital LLC Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

April 1 at 6:45 AM | marketbeat.com

UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Centric Wealth Management

April 1 at 6:37 AM | marketbeat.com

Headlands Technologies LLC Buys 6,563 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

April 1 at 6:36 AM | marketbeat.com

Elwood Capital Partners LP Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

April 1 at 6:28 AM | marketbeat.com

Geode Capital Management LLC Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

April 1 at 6:20 AM | marketbeat.com

Nemes Rush Group LLC Raises Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

April 1 at 6:10 AM | marketbeat.com

Tradewinds LLC. Sells 606 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

April 1 at 5:59 AM | marketbeat.com

National Bank of Canada FI Sells 356,165 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

April 1 at 5:58 AM | marketbeat.com

UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Roundview Capital LLC

April 1 at 5:58 AM | marketbeat.com

UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Cannell & Spears LLC

April 1 at 5:42 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality
By Jeffrey Neal Johnson | March 10, 2025
View Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality
Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
By Thomas Hughes | March 6, 2025
View Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
Is BigBear.ai's 25% Plunge a False Alarm or Fire Sale?
By Jeffrey Neal Johnson | March 7, 2025
View Is BigBear.ai's 25% Plunge a False Alarm or Fire Sale?
Why Archer Aviation Stock Could Soar After Palantir Partnership
By Jeffrey Neal Johnson | March 20, 2025
View Why Archer Aviation Stock Could Soar After Palantir Partnership
4 EV Stocks Facing Uncertainty—Which Ones Will Survive?
By Thomas Hughes | March 7, 2025
View 4 EV Stocks Facing Uncertainty—Which Ones Will Survive?

UNH, MDT, ABT, MCK, CVS, CI, SYK, CAH, HCA, and FMS Company Descriptions

Abbott Laboratories NYSE:ABT

$132.10 +0.41 (+0.31%)

Closing price 03:58 PM Eastern

Extended Trading

$128.28 -3.82 (-2.89%)

As of 07:28 PM Eastern

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Cardinal Health NYSE:CAH

$138.82 +1.69 (+1.23%)

Closing price 03:58 PM Eastern

Extended Trading

$137.12 -1.70 (-1.23%)

As of 07:03 PM Eastern

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

The Cigna Group NYSE:CI

$332.09 +1.09 (+0.33%)

Closing price 03:58 PM Eastern

Extended Trading

$324.32 -7.77 (-2.34%)

As of 07:18 PM Eastern

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

CVS Health NYSE:CVS

$68.14 +0.16 (+0.24%)

Closing price 03:59 PM Eastern

Extended Trading

$67.39 -0.75 (-1.10%)

As of 07:26 PM Eastern

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Fresenius Medical Care NYSE:FMS

$24.73 -0.01 (-0.04%)

Closing price 03:58 PM Eastern

Extended Trading

$24.11 -0.62 (-2.51%)

As of 06:36 PM Eastern

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

HCA Healthcare NYSE:HCA

$347.48 +1.75 (+0.51%)

Closing price 03:59 PM Eastern

Extended Trading

$345.95 -1.53 (-0.44%)

As of 07:23 PM Eastern

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

McKesson NYSE:MCK

$694.12 +20.43 (+3.03%)

Closing price 03:58 PM Eastern

Extended Trading

$686.84 -7.28 (-1.05%)

As of 07:27 PM Eastern

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Medtronic NYSE:MDT

$88.97 +0.48 (+0.54%)

Closing price 03:58 PM Eastern

Extended Trading

$87.18 -1.80 (-2.02%)

As of 07:23 PM Eastern

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Stryker NYSE:SYK

$377.82 +4.52 (+1.21%)

Closing price 03:58 PM Eastern

Extended Trading

$368.85 -8.97 (-2.37%)

As of 07:18 PM Eastern

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

UnitedHealth Group NYSE:UNH

$523.61 +0.49 (+0.09%)

Closing price 03:58 PM Eastern

Extended Trading

$520.50 -3.11 (-0.59%)

As of 07:28 PM Eastern

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest UNH, MDT, ABT, MCK, CVS, CI, SYK, CAH, HCA, and FMS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest UNH, MDT, ABT, MCK, CVS, CI, SYK, CAH, HCA, and FMS Earnings

Compare Dividends

Latest UNH, MDT, ABT, MCK, CVS, CI, SYK, CAH, HCA, and FMS Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

UNH, MDT, ABT, MCK, CVS, CI, SYK, CAH, HCA, and FMS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

UNH, MDT, ABT, MCK, CVS, CI, SYK, CAH, HCA, and FMS Company Descriptions

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools